China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.
The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.
These vaccines have not yet been approved by the World Health Organization
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
A technical advisory group of the UN health agency which met on Tuesday has sought "additional clarifications" from Bharat Biotech for Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
'The Union government has discouraged state and local governments from imposing restrictions on their own.' 'That advice should be withdrawn,' asserts Mihir S Sharma.
Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
Babychakra's online community has 500,000 mothers seeking advice and support and who share lessons learnt on their journey through pregnancy and parenthood.
Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga
Weeks after the second wave peaked in many parts of the country, we are rapidly forgetting what happened to our hospitals, cautions Mihir S Sharma.
Once the patients are identified, the government will decide on the quantum of compensation in each case and then approach J&J for claim settlement.
Ace shuttler PV Sindhu, on Wednesday, said her dream is to become World No 1 and she is trying to reach the numero uno spot.
The vaccination rate needs to go up by three to four times, assert Ajay Shah and Amrita Agarwal.
Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.
The biggest spender was Tata Motors, with Rs 4,224.6 crore assigned under the R&D head.
The CEOs round table is expected to be attended by Apple chief Tim Cook, Walmart head Doug McMillon, Caterpillar's Jim Umpleby, Google head Sundar Pichai and Microsoft's Satya Nadella.
Multinational consumer goods company Procter & Gamble has been named world's best company in terms of leadership followed by General Electric and Coca-Cola in the second and third place respectively, as per a Hay Group study.
Tech companies typically do lots of business overseas and book profits in low-tax jurisdictions.
Mumbai-based BabyChakra is among the four start-ups Google has shortlisted from India for the fifth batch of its mentorship programme
The coronavirus dominated the opening minutes of the Trump-Biden face-off in Nashville with US President Trump terming the contagion a "worldwide problem".
While the November 2017 round of rate revisions saw mainly eating joints unwilling to pass on GST benefits, this time round, sanitary napkin makers, TV manufacturers and even paint companies have said passing on GST benefits is not a feasible exercise.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
Sanam Re is a moronic film, feels Sukanya Verma.
Ratul Narain -- the entrepreneur behind Bempu -- tells Shobha Warrier that despite the challenges and frustrations, he is living his dream.
American CEOs expected to meet Modi on Sunday include Apple's Tim Cook, Walmart's Doug McMillon, Caterpillar's Jim Umpleby, Google's Sundar Pichai and Microsoft's Satya Nadella.
The verdict followed a $72 million jury award from the same court in February to the family of a woman, who died from ovarian cancer.
The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.
'An influencer is expected to have upwards of 100,000 followers across various social media platforms of YouTube, Instagram, Facebook, Twitter etc,' points out brand strategist Ambi Parameswaran, founder, Brand-Building.com.
Prime Minister Narendra Modi was welcomed by over 500 Indian-Americans who had gathered outside the Waldorf Astoria Hotel on Thursday.
'They are starting to move more quickly and we would just like to continue to see bold action being taken.'
Reliance ADAG, Tech Mahindra among top recruiters at IIM-A
FMCG has been behaving unlike a defensive category in recent quarters.
"Rather than putting pressure on the businesspeople of the Manufacturing Council & Strategy & Policy Forum, I am ending both. Thank you all!" Trump said in a tweet.
Walmart is rumoured to be looking to listing Flipkart in a few years. At that stage, we'll get a better sense of what's going on in retail, says Devangshu Datta.
'People can relate to him much the way they did with a young Sachin Tendulkar 30 years ago.'
The 30-share Sensex ended up 142 points at 29,462 and the 50-share Nifty gained 26 points to end at 8,895.
First acquisition under Sikka's plan of buying technologies for tomorrow
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances